As of September 2026, 36 paid clinical trials are recruiting for Lung disease in Kansas City, Kansas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Kansas City, KS at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Medical Center | Cystic Fibrosis, Heart Failure, Obesity | 179 |
| University of Kansas Cancer Center | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | 82 |
| The University of Kansas Medical Center | Adenoma, Adjustment Disorder, Ankle Fracture (bimalleolar Equivalent, Bimalleolar, or Trimalleolar) | 21 |
| Kansas University Medical Center | DM1, Myotonic Dystrophy 1, Acute GVHD | 12 |
| University of Kansas | Idiopathic Pulmonary Fibrosis, Lung Diseases, Asthma | 9 |
| University of Kansas Hospital | Prostate Cancer, Atrial Fibrillation, Cardiovascular Disease and Lipoprotein(a) | 9 |
| Clinical Trial Site | Transthyretin Amyloidosis With Cardiomyopathy, ATTR Amyloidosis, High Cardiovascular Risk | 5 |
| The University of Kansas Cancer Center | AML, AML With Mutated NPM1, Abdominal Neoplasm | 5 |
| The University of Kansas Cancer Center, Westwood Campus | NSCLC Stage IV, Locally Advanced Lung Carcinoma, Lung Cancer | 5 |
| University of Kansas Medical Center Research Institute | Gastroesophageal Junction Adenocarcinoma, COPD, Carcinoma, Non-Small Cell Lung | 5 |
| University of Kansas Medical Center Research Institute, Inc. | Acute Myeloid Leukemia, Atrial Fibrillation, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | 5 |
| University of Kansas Medical Center (KUMC) | Complex Cardiovascular Surgery With Cardiopulmonary Bypass, FGFR Gene Alterations, FGFR Gene Amplification | 4 |
| Alkermes Investigational Site | Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia | 3 |
| Clinical Associates Midwest, LLC | Acute Treatment of Migraine, Pediatric Migraine | 2 |
| GSK Investigational Site | Asthma, Influenza, Human | 2 |
| Mobility and Falls Lab | Multiple Sclerosis, Parkinson's Disease (PD), Spasticity | 2 |
| Teva Investigational | Multiple System Atrophy | 2 |
| The University of Kansas | Aortic Stenosis, Cystitis Recurrent, Recurrent UTIs | 2 |
| The University of Kansas Cancer Center - Westwood | Advanced NSCLC, Breast Cancer, Lung Cancer | 2 |
| The University of Kansas Health System | Acute Ischemic Stroke, Burns, Skin Graft Complications | 2 |
| The University of Kansas Hospital | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 2 |
| The University of Kansas Medical Center Medical Office Building | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 2 |
| Univeristy of Kansas Medical Center | Alzheimer Disease, FSHD, Healthy Aging | 2 |
| University of Kansas Health System | Cesarean Delivery, General Anesthesia, Lower Urinary Tract Symptoms | 2 |
| University of Kansas Medical Center Research Institute Inc. | Lewy Body Dementia Psychosis | 2 |
Recruiting trials in Kansas City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 462 recruiting clinical trials in Kansas City, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Kansas City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Kansas City include Heart Failure (11), Cystic Fibrosis (10), Acute Myeloid Leukemia (9), Obesity (8), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Kansas City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Kansas City include University of Kansas Medical Center, University of Kansas Cancer Center, The University of Kansas Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Kansas City are Cancer & tumors (122), Neurology & pain (47), Cardiovascular (40). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.